SERETIDE 125 micrograms/25 micrograms/dose, suspension for inhalation in a pressurised container with metering valve 120 doses
Active ingredients: Fluticasone propionate, Salmeterol, Salmeterol xinafoate
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for inhalation120 dosesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SERETIDE 125 microgrammes/25 microgrammes/dose, suspension pour inhalation en flacon pressurisé avec valve doseuse
- Pharmaceutical form
- suspension pour inhalation
- Route of administration
- inhalée
- Presentation description
- 1 flacon(s) pressurisé(s) aluminium de 120 doses avec valve(s) doseuse(s) avec embout(s) buccal(aux)
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Sept 2001
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69505268CIP73565872CIP133400935658722Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPIONATE DE FLUTICASONEsuspension | 125 microgrammes · une dose | SA |
| SALMÉTÉROL BASEsuspension | 25 microgrammes · une dose | FT |
| XINAFOATE DE SALMÉTÉROLsuspension | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.